Oncological Implications of the Interval between Neoadjuvant Therapy Completion and Surgery in Patients with Pancreatic Ductal Adenocarcinoma
Gabriella Lionetto, S. Paiella, Mark D. Danese, F. Casciani et autres
0 citationsHPB
G. Malleo
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
6Publications signalées
1Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
Pancreatic and Hepatic Oncology ResearchMicroRNA in disease regulationCancer Cells and MetastasisRenal cell carcinoma treatmentOvarian cancer diagnosis and treatment
Publications récentes
Delta-function: Proof of Concept and Application to CA19-9 Variations for Survival Prediction after Neoadjuvant Chemotherapy in Pancreatic Adenocarcinoma
J. Garnier, A. Marchetti, Bruce H. Campbell, P. Andel et autres
0 citationsHPB
Integrative characterization of intraductal tubulopapillary neoplasm (ITPN) of the pancreas and associated invasive adenocarcinoma
Andrea Mafficini, M. Simbolo, T. Shibata, S. Hong et autres
0 citationsPancreatology
Integrative characterization of pancreatic ductal adenocarcinoma with poorly cohesive / signet ring cells
Claudio Luchini, M. Simbolo, N. Silvestris, A. Mafficini et autres
0 citationsPancreatology
Associations between pancreatic expression quantitative trait loci (eQTLs) and pancreatic ductal adenocarcinoma risk.
Manuel Gentiluomo, Laura Pistoni, Giulia Peduzzi, Y. Lu et autres
1 citationPancreatology
Supplementary Material for: Mixed Adenoneuroendocrine Carcinomas of the Gastrointestinal Tract: Targeted Next-Generation Sequencing Suggests a Monoclonal Origin of the Two Components
Maria Scardoni, E. Vittoria, Marco Volante, Borislav C. Rusev et autres
0 citationsFigshare
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.